The OHSU leadership team makes the difficult decision to pause recruitment for new H-1B visa applicants, due to changing federal guidance and the recently imposed filing fee of $100,000 per person.

Nike and Doernbecher introduce the 2025 Doernbecher Freestyle collection, created by Doernbecher patient-designers. The 21-year-old Nike-OHSU Doernbecher Freestyle partnership has raised more than $40 million for the children's hospital.

In response to a study that found getting the COVID-19 messenger RNA vaccine appears to enhance the effectiveness of a type of cancer immunotherapy, Mark Slika, Ph.D., says: “I’m cautiously optimistic about these results."

Mosaic Community Health clinic in Madras is partnering with OHSU Casey Eye Institute to offer vision tests for the first time. OHSU technicians bring an eye scanner to the clinic every other Monday to screen for vision loss, diabetic retinopathy, cataracts, glaucoma and more.

OHSU’s Oregon Institute on Occupational Health Sciences cosponsors a video/graphic design contest focused on improving workplace safety and health for younger workers, with a goal of encouraging teen workers to take the Oregon Occupational Safety and Health Division’s online heat-illness prevention course.

Continued coverage of a unique proof-of-concept to treat infertility by turning skin cells into eggs capable of producing early human embryos.

Continued coverage of a unique proof-of-concept to treat infertility by turning skin cells into eggs capable of producing early human embryos.

Nike and Doernbecher introduce the 2025 Doernbecher Freestyle collection, created by Doernbecher patient-designers. The 21-year-old Nike-OHSU Doernbecher Freestyle partnership has raised more than $40 million for the children's hospital.

Nike and Doernbecher introduce the 2025 Doernbecher Freestyle collection, created by Doernbecher patient-designers. The 21-year-old Nike-OHSU Doernbecher Freestyle partnership has raised more than $40 million for the children's hospital.

GRAIL PATHFINDER 2 study finds Galleri, a multi-cancer early detection blood test, increased cancer detection more than seven-fold when added to U.S. Preventive Services Task Force A and B recommended screenings; OHSU principal investigator Nima Nabavizadeh, M.D., says: “Cancer screening saves lives, but we routinely screen for just four or five cancer types in the United States today and approximately 70% of cancer deaths come from cancers that do not have standard-of-care screening and are typically caught too late. Data from PATHFINDER 2 show that Galleri could fundamentally change our approach to cancer screening, helping to detect many types of cancer earlier, when the chance of successful treatment or even cure are the greatest.”